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1982.-Gastric HCOY transport (basal) studied in isolated amphibian mucosa and mammalian stomach in vivo amounts to 2-10% of maximal H' secretion. Duodenal mucosa, devoid of Brunner's glands, transports HCO; at a greater rate (per unit surface area) than either stomach or jejunum in vitro and in vivo. Gastric (but not duodenal) HCOT transport is stimulated by dibutyryl cGMP, carbachol, and cholecystokinin and duodenal (but not gastric) transport by dibutyryl CAMP and gastric inhibitory peptide. Glucagon and E-and F-type prostaglandins stimulate, whereas histamine, gastrin, and secretin are without effect in both stomach and duodenum.
Gastric transport very probably occurs by Cl--HCO; ex h c ange at the luminal membranes of the surface epithelial cells. In addition to this mechanism, the duodenum also transports HCO; electrogenically.
Lowering the luminal pH increases transport in both the stomach and duodenum.
This response, probably mediated via both local production of prostaglandins and tissue-specific humoral agents, may be important in mucosal protection against acid. Metabolism-dependent transport of HCO:, stimulated by acid, seems quantitatively sufficient to account for all of the duodenal and most of the gastric mucosa's ability to remove luminal acid. bicarbonate transport; duodenal hormones; prostaglandins mucosa; gastric mucosa; gastrointestinal EVIDENCE INDICATING that gastric mucosa secretes HCOY in addition to H+ was presented as early as 1892 by the Danish physiologist Schierbeck (79). Furthermore, his results suggested that HCO; secretion by the stomach could be stimulated. Thus, in carefully controlled experiments in dogs, it was observed that a sham-feeding maneuver increased not only acid secretion but also the amount of CO2 appearing in the gastric lumen. Levels of CO2 tension attained (X00 mmHg) were considerably higher than in blood and indicative of gastric intraluminal neutralization of H+ by HCO;. Later, Hollander (52) postulated secretion of an alkaline fluid that was produced at a constant rate and originated from nonparietal sources.
In recent years, use of spontaneously secreting antral preparations and fundic preparations after potent inhibition of H+ secretion has enabled direct measurement and characterization of some of the properties of gastric HCOT transport. Studies with in vitro amphibian antral (16, 17, 30) and fundic (16, 17, 21, 33 ) mucosa and rabbit (32) antral mucosa have shown that transport is dependent on tissue metabolism, sensitive to a variety of agents, and very probably originates from surface epithelial cells. Sensitivity of HCO; transport to several potential ulcerogens and the stimulatory effect of ulceroprotective agents such as prostaglandins and glucagon have led to the proposal that it may serve a protective function (3, 16, 17, 18, 26, 30, 37) . Techniques have also been developed for direct studies on gastric HCO; transport in the mammalian stomach in vivo. Transport of HCOT with properties similar to those occurring in amphibian mucosa in vitro has been demonstrated in the guinea pig (24, 35) , dog (8, 38, 39, 57, 67) , and cat (42)) and work in humans (72) has been initiated.
The finding of HCO; transport by gastric surface epithelial cells and the possibility that it serves a protective function made it interesting to study whether duodenal epithelium possesses a similar ability to transport HCOY. It was found that duodenal preparations, devoid of Brunner's glands, secrete HCO: at considerably higher rates than the stomach or lower parts of the small intes-and in mammals in vivo (25, 29, 41) . The stimulatory pathways as well as the mechanism of duodenal HCO; transport do, however, show distinct differences from those in the stomach.
The purpose of the present survey is to discuss some of the methodology developed for studying gastroduodenal HCOT transport, to summarize present knowledge about its properties including the stimulatory effect of luminal acid, and to discuss its possible role in acidity regulation and mucosal protection.
Gastric Mucosa
Methods in vitro. With antral mucosa mounted as a flat sheet in an in vitro chamber, luminal alkalinization can be titrated directly (17, 30) . This preparation has no or very few H'secreting cells. However, studies using gastric fundus must contend with the problem that HCO; transport is usually masked by a simultaneous and higher rate of H+ transport. It can be disclosed by inhibition of H+ transport with specific inhibitors such as thiocyanate (SCN-) or histamine Hz-receptor antagonists or by use of species where spontaneous arrest of H+ transport occurs (17). Neither SCN-(30) nor histamine Hz-antagonist (37) affects gastric transport of HCOi. sient decline increases the amount of alkali titrated (at pH 7.40) on the luminal side. Simultaneously, there are decreases in mucosal electrical potential difference (PD) and resistance, indicating increased mucosal ionic permeability. Use of N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer (gassed with 100% 02) instead of HCO; on the nutrient side can be used to show that ethanol is a potent inhibitor of metabolism-dependent transport (Fig. 1) . Both nutrient HCO; and HEPES very probably permeate the ethanol-treated low-resistance mucosa, but only HCO; being a volatile buffer is titrated. Lower concentrations of ethanol inhibit metabolism-dependent HCOY transport without inducing passive leakage of this ion (21). It is also probable that, if very high concentrations of ethanol or other permeability-increasing agents are used, only the increased passive leakage of HCO; may be recorded. The gastric antrum is a more "leaky" epithelium than the fundus (83), and ( paq, cm*, h-'1 Ethanol ( 14 'A ) 0.6 -Use of luminal pH levels of 7.40 or higher excludes the possibility of alkalinization of the luminal side resulting from passive diffusion of H+ ions into the mucosa. Luminal alkalinization may then reflect secretion of HCOT (or OH-) or active absorbtion of H+. If secretion of HCOB is the case or if the net effect of another transport process is appearance of HCO; on the luminal side (cf. Ref. 9), it should be pointed out that continuous gassing of the luminal bathing solution with 100% 02 as usually used, by removal of CO2 fromHC0;
(and thus formation of OH-), will increase its pH. The pH level used for titration may thus differ from that of the original alkaline secretion, but titration will nevertheless, under steadystate conditions, be a quantitative estimate of the amount of HCOY transported.
Removal of CO2 requires rapid gassing of the luminal fluid in contact with the mucosa. Chambers appropriate for this purpose have been described by Rehm (73). and stimulated by the cyclic nucleotide dibutyryl cGMP (DBcGMP) , prostaglandins, and low concentrations of some hormones, strongly suggesting it to be an active process. It is also independent of HCOT (and CO%) on the nutrient side (17, 26, 37) . In most experiments in vitro, however, the nutrient bathing solution is buffered with this ion (and COa), comparable with gastric mucosa in vivo that is exposed to tissue and blood HCOT. This raises the problem that some agents, by increasing paracellular or other pathways of the normally tight (84) gastric fundic epithelium, may induce leakage of HCOY into the luminal solution. It is important to distinguish between this phenomenon and metabolism-dependent HCOT transport. Experiments illustrating this point with respect to the effects of ethanol on frog fundic mucosa are shown in Fig. 1 (38, 39, 57, 67) . With this technique, adequate removal of CO2 formed during reaction between secreted HCO; and titrant (acid) is necessary. Accumulated CO2 may otherwise acidify the perfusate and thus apparently inhibit alkalinization.
An alternative approach enables gastric secretion of both HCOF and H+ to be measured simultaneously from determination of gastric intraluminal pH and CO2 tension (23, 35) . A prerequisite for this technique is that gastric mucosal permeability to CO2 is low so that intraluminal CO2 originates mainly from reaction between secreted HCO; and H+. Differential effects of CO2 applied to secretory (mucosal) and nutrient (serosal) sides of in vitro frog preparations (54) suggest low CO:! permeability. Experimental data in vivo have demonstrated low mucosal permeability to CO2 in both the guinea pig (35) and dog (58) stomach, and methodology based on intragastric pH and CO2 tension measurement has recently been adapted for studies of HCO; transport in humans (72).
Direct titrations at low values of gastric intraluminal pH cannot distinguish between H+ removal due to passive diffusion and secretion of HCO;. In addition, measurement of HCO; from intraluminal CO2 under such conditions (58) is likely to give an underestimate of HCO: transport; reaction between HCO: and H+ with release of CO2 occurring in closer vicinity to the luminal cell membranes (see below) may thus facilitate increased absorption of COZ.
Increases in mucosal permeability with ensuing passive leakage of HCO; constitute a similar problem when evaluating the nature of increases in HCO; appearance in gastric lumen in vivo as in vitro. Davenport (11) demonstrated that high concentrations of acetylsalicylic acid not only increase apparent removal of H+ from the gastric lumen but also induce leakage of plasma proteins and glucose into the lumen, indicating creation of pathways for their passive transmucosal migration. Increases in mucosal passive permeability in vivo have also been estimated from gastric absorption of saccharide macromolecules (27,28) and mucosal permeability to horseradish peroxidase (68). It has been observed that some procedures, including gastric intraarterial injection of acetylcholine (4), increase ultrafiltration of large amounts of protein and ions, including HCO;, into the gastric lumen.
Gastric output of Na' has been used frequently as an index of nonparietal alkaline secretion (52,66). However, HCOT transport probably occurs by Cl--HCOT exchange (21), and passive components of Na' flux across gastric mucosa (51, 65) have been demonstrated. Interestingly, pathways for Na' transport depend on luminal pH in both antral (5) and fundic (59) mucosa. Thus, Na' in gastric juice may not be a precise quantitative estimate of HCO; transport.
Properties and origin of metabolism-dependent gastric HCOT transport. Properties of gastric HCO; transport examined in amphibian fundic mucosa are summarized in Table 1 . Basal transport amounts to 0.2-0.5 peq. crne2 l h-l, and DBcGMP, carbachol(17), cholecystokinin, glucagon (26)) and prostaglandins (37) increase transport. Stimulation by calcium ions very probably reflects mucosal release of acetylcholine, inasmuch as it is inhibited by atropine or magnesium ions (23). Inhibition by acetazolamide is asymmetric because 10v4 M is sufficient to produce an effect on the luminal side, whereas 10m2 M is required on the nutrient side (17). Atropine abolishes stimulation by carbachol but does not affect basal HCOT transport (23, 35). Well-known stimulants of gastric H+ transport such as histamine, gastrin, or DBcAMP are without effect on gastric HCO; transport (17, 18), indicating that stimulatory pathways for HCOY are different from those for H+ transport.
Gastric mucosal surface epithelial cells contain most of the mucosal activity of cGMP diesterase (87) and carbonic anhydrase (46), and the concentrations of DBcGMP or acetazolamide affectingHC03 transport are considerably lower than those necessary to exert an effect on H+ secretion (17). Antral mucosa is composed mainly of surface epithelial cells, and there is close morphological similarity between surface epithelial cells in fundus and antrum. In addition, fundic and antral metabolism-dependent HCO; transports display almost identical properties. These findings strongly suggest that transport originates from the surface epithelial cells (17). It is interesting that cholinergic stimuli elevate mucosal con-G186 G. FLEMSTRijM AND A. GARNER centrations of cGMP in both fundus and antrum (10) together with increasing HCO: transport. This suggests that nucleotide increases are located in the surface cells, and cGMP may serve the role of an intracellular messenger in choline@ stimulation of HCO; transport. In this connection, histamine Hz-receptor antagonists attenuate the rise in CAMP (but not cGMP) in response to acetylcholine in fundic mucosa (15).
Removal of luminal (but not nutrient) Cl-abolishes HCO: transport by frog fundic mucosa, and stimulation of transport, in contrast to H+ transport, is not l associated with changes in mucosal . PD or electrical resistance. These findings together with its greater sensitivity to luminal acetazolamide suggest that alkalinization occurs by electroneutral Cl--HCO; exchange at the luminal cell membrane (20, 21 cme2 l h-l) or antrum (-0.45 peq* cmv2 l h-l). The duo-
transport. Stimulants and inhibitors of transport in prox-
imal bullfrog duodenum are summarized in Table 2. denum also shows some distinct differences from the stomach with regard to stimulation of HCO;
Basal transport of HCOT (-1.0 ,ueq l crne2* h-') in this transport species is greater than that in gastric fundus (-0.55 peq. transport depend on both the "nature" of basal transport and the particular stimulant used the luminal membrane results in a net electrogenic to increase transport. In mucosae from frogs kept at -10 HCOT transport. NaHCOy across the nutrient membrane and then recytransport in vitro, is stimulated by (luminally adminiscles at this membrane due to the activity of an ouabaintered) E-type prostaglandins, and the increase in transsensitive Na'-K'-ATPase. and GIP (injected intravenously) produce similar responses to those found in vitro; there is thus a rise in HCO, transport but no change in PD (25, 29). Both indomethacin (29) and acetazolamide (1) inhibit alkalinization, whereas secretin (25) is without effect. Thus, although secretin is a stimulant of ,pancreatic HCOT transport, it is without effect on either gastric or duodenal HCOT transport in vitro and in vivo. These data strongly suggest that the in vitro amphibian mucosa provides a representative model for conditions pertaining to mammalian duodenum in vivo.
In a recent report (85), effects of cysteamine on a variety of enzyme activities in rat duodenal mucosal cells are described. Specific inhibition of brush-border alkaline phosphatase was demonstrated, and it is proposed that this enzyme via HCO&stimulated ATPase activity is part of the duodenal HCOT secretory mechanism. Cysteamine has been reported to inhibit duodenal HCOF transport in rats, and the duodenal ulcerogenic activity of this agent is well known (1).
Stimulation of Gastroduodenal NC03 Transport by Luminal Acid
It is well established that the rate of removal of luminal HCl either instilled or secreted into the stomach increases with increasing concentration of the acid. This has been interpreted as evidence for passive diffusion of H+ along the chemical gradient into the mucosa (69,90). An alternative explanation would be that acid within the lumen of the stomach stimulated mucosal transport of HCOT or that a combination of these mechanisms occurred. Recent work has demonstrated that luminal acid stimulates HCOi transport (38). Thus instillation of 10 mM HCl into the lumen of the gastric remnant increased titratable alkalinity of fluid perfusing the (vagally denervated) dog fundic pouch (Fig. 3) . Interestingly, this response wa .s associated with an increase in pl .asma enteroglucagon (38, 39). Exposure of the lumen of cat duodenum, devoid of Brunner's glands, and pancreatic or bile HCO: to lo-25 mM HCl increased HCO; transport (29, 41) . This response in the cat was associated with increased PGE2 and decreased DNA appearance in the luminal perfusate (41). The reduction in DNA indicates that the rise in HCO: was not the result of cellular desquamation and further suggests that increased HCOT transport in response to luminal acid offered sufficient protection of the mucosal surface. Although acidstimulated HCO: transport in control animals was sustained (cf. Fig. 4) ) the response was only transient in cats pretreated with indomethacin (41), su ggesting that endogenous prostaglandin is involved in maintaining "steady-state" secretory rates. Definitive evidence for humoral components in mediation of the response to luminal acid has been presented by Heylings et al. (47, 48) in experiments where two frog fundic or duodenal mucosae were mounted in parallel with their nutrient (blood) surfaces facing the same buffered solution. Lowering the pH on the luminal (secretory) side of one mucosa caused an increase inHC03 transport by the other (not exposed to acid) tissue. Luminal acidification of one fundus transiently increased HCOT transport by a parallel fundus. A similar transient response occurred on unilateral acidification in pairs of duodenum, whereas fundic acidification did not affect a parallel duodenum, suggesting tissue-specific mediation of the fundic response. However, duodenal acidification caused a sustained increase in HCOT transport by a parallel fundus (J. R. Heylings, A. Garner, and G. FlemStrom, unpublished data). In addition to local (prostaglandin) and humoral stimuli, intrinsic nervous reflexes may also be involved (Fig. 5 ). This possibility, however, has not been tested. Both passive diffusion of H+ (69,90) and neutralization and dilution by nonparietal (52,66) secretions have been proposed to account for the continuous removal of H+ secreted or instilled into the stomach. Mathematical treatment of data from experiments where only net acid (H' minus HCO;) is measured probably cannot distinguish between the two processes (66). Therefore, to evaluate whether HCO; transport is quantitatively sufficient to account for disappearance of acid, rates of this transport and H+ loss were compared in dogs with Heidenhain pouches (41) . Acid disappearance calculated by linear regression analysis of the relation between acid output and secretory volume (on stimulation by histamine) was 157 t 11 peg/h. This method provides a good estimate of the acid loss occurring at high and medium rates of H+ secretion (Ref. 69, p. 69) . Basal HCO; transport after inhibition of H+ secretion in the same pouches was 53 t 4 peq/h, and instillation of 10 mM HCl into the remnant of the main stomach increased HCO: transport in the pouch to 105 t 16 peq/h. These results indicate that, at high rates of H+ secretion, in addition to being neutralized by secreted HCOY, some intraluminal acid (approximately one-third) could be removed by diffusion. However, it should be noted that exogenous acid was not instilled into the HCOi-secreting pouch. Local mucosal mechanisms may increase HCO; transport further in tissues directly exposed to acid.
These experiments were performed on dogs with intact mucosa. Davenport (11) able to ions and larger molecules. It is very likely that, under conditions of increased permeability, H+ diffuse out from (and HCOY into) the gastric lumen. Gastric nonparietal secretion has been postulated to have a defined volume (52, 66) . It seems likely, however, that, due to the higher mobility of H', neutralization of HCOY occurs in close vicinity to the luminal surface of the epithelium. Reaction between H+ and HCO; should reduce osmolarity of the combined secretion, and excess water probably moves along its chemical gradient into the mucosa (cf. Ref. 13) . Gastric transport of HCOY may therefore appear as a surface neutralization reaction as opposed to secretion with a defined volume. This contention would also be consistent with a HCO:-Cl-exchange process.
Duodenal HCO; transport stimulated by prostaglandins or luminal acid amounts to 0.3-0.4 peq. crnD2. min-' in the cat and to -0.5 peq. cm-2*min-1 in the guinea pig (25) . These rates are similar to the rate of loss of H+ from instilled acid in the dog proximal and distal duodenum (-0.6 peq l crnB2 l min-' ). Direct titration (25, 29, 41) gives considerably higher values of duodenal HCO: transport than estimates made on the basis of duodenal intraluminal CO2 tension (44, 49) . This difference probably reflects removal of some CO2 by duodenal mucosa.
Proposed Protective Role of Gastroduodenal HCOT Transport
The demonstration that gastric HCO; transport is inhibited by several potential ulcerogens, including nonsteroidal anti-inflammatory drugs (33, 34, 36, 70) , ethanol (Zl), a-adrenergic agonists (US), and acetazolamide (17, 30, 58) , and stimulated by ulceroprotective agents (74,76, 88) such as prostaglandins (8, 37, 39, 42, 57, 67) and glucagon (26) suggests that metabolism-dependent HCO; transport is one component in mucosal protection against acid. Acetazolamide abolishes the ability of canine gastric mucosa to resist concentrations of luminal acid higher than 25 mM (92) and prevents the ulceroprotective action of PGEZ in the rat (61). Sympathectomy prevents development of gastric stress ulcers in the dog (53). The inhibition of HCOY transport by taurocholate in gastric (but not in duodenal) mucosa might relate to the gastric ulcerogenic activity of bile acids. of H+ occurred in the luminal bulk solution (18). Transport of HCO; into a surface boundary of low turbulence would considerably enhance its protective effect. The thin layer of viscoelastic mucus adherent to the mucosa consists of a matrix of glycoprotein molecules, which form a gel joined by physical noncovalent interactions. Properties of this gel, recently reviewed by Allen (2) and Allen and Garner (3), seem appropriate to support H+ and HCOY gradients (Fig. 6) . The gel is continuously formed by the mucus cells and degraded and solubilized at its luminal surface by pepsin. It is permeable to small ions but impermeable to pepsin. Prostaglandins stimulate gastric production of both mucus (7,56) and HCO:, whereas the ulceroprotective drug carbenoxolone (7,70) and the hormone secretin (26, 39, 50) increase only the former, indicating, at least in part, different stimulatory pathways for mucous secretion and HCOT transport. Teorell examined counterdiffusion of acid and base in a membrane model as early as 1936 (89) and also pointed out (91) that the profile of the ion gradients in a boundary depends on the amounts of acid and base available for diffusion, the mobilities of these and other ions present, its electrical charge, and the transboundary electrical potential. Later, Heatley (45), on the basis of studies on gastric mucus in vitro, proposed that counterdiffusion of H+ and HCOT occurs at the surface of gastric mucosa. Direct evidence for the occurrence of a pH gradient across the gastric mucous gel in the rabbit fundus in vitro was presented recently (93). With pH-sensitive microelectrodes, it was shown that pH at the cell membrane is slightly alkaline (-7. 3), in spite of that in the luminal bulk solution being acid (-2.3). Interestingly, CN-, an inhibitor of HCOT transport, abolished the pH gradient. Similar findings have been made using acetylsalicylate in vivo (75). dependent HCOT transport nevertheless seems sufficient for protection at intraluminal pH values that normally prevail in the stomach. A "second line" of defense may be provided by intracellular neutralization of H+ in the surface epithelial cells by HCOT transported into these cells by Cl--HCOg exchange at the nutrient membrane (60). It is also possible that protein from cells exfoliated into the mucous gel buffers (6) and thus retarded access of H+ to the mucosal surface. Exposure of dog gastric mucosa to 50 mM (but not 10 mM) HCl results in an increase in release of DNA into the lumen, indicating exfoliation of mucosal cells (40). Interestingly, exfoliation is inhibited by exogenous prostaglandins in both dogs (40) and humans (76).
Luminal membrane carbonic anhydrase activity, which is probably involved in gastric secretion of HCO;, is absent only in parietal and zymogen cells (46). Although less in the zymogen cell, the luminal (but not basal) membrane of both these cell types demonstrated H+-K+-ATPase activity (77). This activity has been shown to be part of the H+ secretory process of the parietal cell (78), and ability to excrete H+ might render these cells within the fundic glands less sensitive to acid.
Gastric mucosal resistance to acid is, however, probably multifactoral, and it cannot presently be ascertained whether HCO: transport is sufficient to maintain a neutral pH at the luminal cell membrane with values of pH in the luminal bulk solution below 1.5-2.0. MetabolismIn the duodenum, it would seem logical that pH at the epithelial surface is more important in protection than pH in the bulk solution. Pancreatic and bile secretion of HCO; are clearly important in regulation of the latter, but, as demonstrated by Florey et al. in several mammalian species (31), duodenum devoid of pancreatic HCOi possesses better ability than lower parts of the small intestine to resist luminal acid, suggesting a role for mucosal cell HCOT transport in duodenal epithelial protection. It should also be noted that prostaglandins at concentrations too low to inhibit gastric H+ secretion 
